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This study reports the results of the detection and quantitation of
cocaine and its metabolites in liver tissues fixed in formalin and in
the formalin solutions in which the same tissues were fixed.
Toxicological analyses were performed on formalin-fixed liver
samples from four cases of death of cocaine abusers and on
formalin solutions (10% buffered, pH 7) in which the samples were
preserved. Analyses carried out at the time of autopsy on body
fluids and tissues allowed identification of cocaine and the
metabolite benzoylecgonine. Liver tissue samples were preserved in
formalin solutions for four weeks before analysis. Results only
showed the presence of benzoylecgonine in the studied materials.
The mean levels of recovery of benzoylecgonine in fixed tissues
were 12.31% in liver and 84.47% in formalin from liver. Results
indicated that benzoylecgonine has good stability, even in
biological specimens subjected to chemical fixation.
Introduction
The use of alternative matrices to plasma and urine in
forensic toxicology is a field of increasing interest, as demon-
strated by the inclusion of this subject in the main topics of the
meeting of the International Society of Forensic Toxicologists
since 1998 (1). Interest focuses mainly on drug analysis of hair,
saliva, and sweat. In deceased persons, the range of specimens
for drug analysis may be extended to solid tissues and gastric
contents. Other matrices are not often used, particularly as re-
gards histological specimens (2–5), whereas forensic toxicology
is required with increasing frequency to perform analysis of
histopathological specimens obtained from medico-legal
autopsies of toxin-related deaths. These specimens are usually
stored in formalin solutions. Some studies have analyzed drugs
in formalin-fixed tissues (2–5) but, to our knowledge, until
now there have been no studies concerning the detection and
quantitation of cocaine in formalin-fixed tissues.
Analysis of cocaine in biological specimens is complicated by
its instability in various biological matrices. It is particularly
vulnerable to hydrolysis in cholinesterase-containing speci-
mens, including blood and plasma. Conventional postmortem
specimens like urine or blood are sometimes not available for
drug analysis. In these cases, alternative specimens may be an-
alyzed. Liver is traditionally used in forensic toxicology to mea-
sure drug concentrations. Cocaine is metabolized in liver and
is present in postmortem specimens (6,7), so it is an appropriate
biological matrix to detect the presence of this substance. The
aim of the present study was to examine the presence and con-
centration of cocaine and its primary metabolite (i.e., ben-
zoylecgonine) in formalin-fixed human liver tissue and in the
formalin solutions in which the same tissue was fixed.
Cocaine and its metabolites in biological material were detected
by means of gas chromatography (GC) with flame ionization
detection (8) and nitrogen-phosphorus detection (9,10). GC–mass
spectrometric (MS) (6,7,11,12) and high-performance liquid
chromatographic (HPLC) methods (13,14) were also applied.
Materials
Toxicological analyses were performed on samples of fresh,
formalin-fixed liver and formalin solutions (10% buffered, pH
7) in which the samples were preserved. These biological ma-
terials came from four cases of death of cocaine abusers. For
each case, at time of autopsy, a sample of liver was drawn that
was separated in two portions; the first one was analyzed im-
mediately, the second was put in formalin. Tissue samples were
preserved in formalin solutions for four weeks before analysis.
Tissue weights, before and after formalin fixation, were checked
and did not turn out to be appreciably modified by preservation
(5).
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Analytical-grade chemicals and reagents were Isolute Certify
Extraction columns (International Sorbent Technology,
Hengoed, Mid Glamorgan), sodium hydroxide (Merck, Darm-
stadt, Germany), methanol  (Carlo Erba, Milan, Italy), hydro-
chloric acid (Carlo Erba), ammonium hydroxide (Sigma, St.
Louis, MO), dichloromethane (Baker, Phillipsburg, NJ), iso-
propyl alcohol (Sigma), N-methyl-N-trimethyl-silyl-trifluo-
roacetamide (MSTFA) (Sigma), cocaine (Alltech, Los Alamos,
CA), benzoylecgonine (Alltech), and scopolamine (Sigma).
Equipment included a homogenizer (Ultra Turrax, Ica Labor
Technik, Milan, Italy), sonicator (model 1210, Bramson, Dan-
bury, CT), centrifuge (model 4218, ALC, Milan, Italy), vortex
mixer (Falc, Bergamo, Italy), Analytichem Vac Elut (SPS 24,
Varian, Bergon op Zoom, The Netherlands), temperature bath
(Carlo Erba thermostatic bath), and GC–MS (Fisons Instru-
ments, Milan, Italy).
Methods
Preparation of samples
Tissues. Five grams of both fresh and formalin-fixed tissues,
both from autopsy sources, were separately crushed and ho-
mogenized in distilled water (1:1) and sonicated for 7–8 h. One
milliliter of HCl 0.1M was added to homogenized solutions, fol-
lowed by sulfosalicylic acid for deproteinization. The solutions
were centrifuged, and the pH of the supernatant was adjusted
to 6 with ammonium sulfate and NaOH (8% in water). One
milliliter of scopolamine solution (1 mg/L in water) as internal
standard (IS) (15) and 2 mL of 0.1M phosphate buffer (pH 6)
were added, and the solutions were centrifuged before the fol-
lowing phase of extraction.
Formalin solutions. Five milliliters of sample were drawn
off. Solutions were evaporated to dryness at room tempera-
ture. Five milliliters of distilled water were added to the residue.
One millilier of scopolamine solution (1 mg/L in water) as IS
(15) and 2 mL of 0.1M phosphate buffer (pH 6) were added, and
the solutions were centrifuged before the following phase of ex-
traction.
Solid-phase extraction
Isolute Certify Extraction columns were used.
Preparation of columns. Columns were conditioned sequen-
tially with 2 mL of methanol and 2 mL of 0.1M phosphate
buffer, pH 7.
Specimen application. Samples were slowly drawn through
the columns under low vacuum (at least 2 min).
Column rinsing. Columns were rinsed sequentially with 2 mL
of water, 3 mL of 0.1N HCl, and 2 mL of methanol and then
dried for 5 min under full vacuum.
Cocaine elution. Analytes were eluted twice with 1 mL of a
dichloromethane/isopropyl alcohol solution (8:2) with 2% am-
monium hydroxide, made fresh daily; eluates were transferred
to 3-mL silanized gradual tubes and evaporated to dryness at
50ºC in a temperature bath under a slow stream of nitrogen.
Derivatization
Extracts were reconstituted with 50 µL of MSTFA and incu-
bated for 15 min at 75ºC in sealed silanized gradual tubes.
GC–MS analysis
The following conditions were applied: a well-coated open-
tubular capillary column (fused silica 30 m × 0.32 mm) was
used; the carrier gas was helium at a low flow rate of 1.5
mL/min. The temperature program was started at 100ºC and in-
creased first to 180ºC at 40ºC/min and then to 310ºC at
10ºC/min. The injection volume was 1 µL (splitless mode).
Electron ionization (70 eV) was used. Mass spectra were
recorded in the range of 70–500. Figure 1 shows the mass
spectrum of benzoylecgonine trimethylsilyl-derivated from a
formalin-fixed liver sample.
Results
The analysis mainly detected and quantitated benzoylecgo-
nine in all the studied materials. Cocaine was detected only in
one case in fresh tissue, but never in fixed tissues or formalin
solutions. Cocaine and benzoylecgonine were identified by
comparing the retention time to that of the internal standard
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Figure 1. Chromatographic results in fixed liver sample. TIC chro-
matogram and SIM analysis at m/z 82, 240, 346, and 361 (A), and mass
spectrum of peak at retention time of 12.928 min of A (B).
scopolamine and the mass spectrum of cocaine and ben-
zoylecgonine standard (cocaine, m/z 182, 82, 303, and 272;
benzoylecgonine-TMS m/z 82, 240, 361, and 346). Quantitation
was carried out by monitoring the abundances of m/z 182 ions
(for cocaine), m/z 82 ions (for benzoylecgonine-TMS), and m/z
138 ions (for scopolamine-TMS, IS) (15). To verify the linearity
of the detector and to calibrate the method, five calibrators
were tested: 0.02, 0.05, 0.1, 0.5, and 1.0 mg/L or mg/kg (cocaine
and benzoylecgonine in formalin solution and liver tissues pre-
viously tested to be negative). Linear regression analysis of the
calibration data showed a correlation coefficient near 1. The
limit of benzoylecgonine quantitation was set at 0.002 mg/L,
with a signal-to-noise ratio of 10. The variation coefficients be-
tween runs and days, retesting five calibrators (0.5 mg/L or
mg/kg) 10 times each day for 10 days, were 4.5 (for formalin so-
lution) and 5.7 (for liver), respectively. The extraction efficiency
of the method was assayed for four liver samples, previously
tested to be negative, spiked with an adequate amount of in-
ternal standard, cocaine, and benzoylecgonine to give a final
concentration of 1 mg/kg. Recovery was 97.8%. The quantita-
tive results for formalin-fixed liver samples and for the for-
malin solutions in which these tissues were preserved are listed
in Table I.
The quantitative values of cocaine and benzoylecgonine ob-
tained in fixed tissues and from the same tissues at the time of
autopsy were quite different because detectable quantities are
redistributed from tissues into the formalin solution. In many
cases, the concentrations of benzoylecgonine in formalin so-
lutions in which liver was preserved were found to be higher
than those recovered in the same fixed tissues. Table II lists
mean levels of benzoylecgonine recovered from liver (both
fixed tissues and formalin solutions in which the tissues were
preserved) compared with the mean levels from the same sam-
ples at the time of autopsy. The best recovery rates were found
in formalin solutions (84.47%). The total sum of recovery rates
in formalin solutions and fixed tissues (84.47% + 12.31% =
96.78%) was comparable to those of the extraction efficiency of
the method (97.8%) and indicates that cocaine and benzoylec-
gonine have good stability. This value may be useful in quali-
tative evaluation of cases.
Discussion
Results indicate that benzoylecgonine could be detected in
fixed liver tissue and in the formalin solutions in which the
specimens were stored. Samples of liver are easily collected
and, as shown also by the procedures used by us, they can be
readily homogenized in water or dilute buffer, and the use of ul-
trasonicating blender is more effective.
Only benzoylecgonine, the main metabolite of cocaine, was
found in the analyzed samples. In the living body, cocaine is
rapidly metabolized (t1/2 = 0.7–1.5 h) to ecgonine methylester
and other fragments by serum cholinesterase and liver esterase
and to benzoylecgonine by chemical hydrolysis. Cocaine is also
hydrolyzed by a liver esterase to benzoylecgonine. Those pro-
cesses probably continue postmortem in blood and liver (7). Hy-
drolysis can be slowed by refrigeration and freezing and by
decreasing the pH below normal. In addition, it has been shown
that, in basic media, the transformation of cocaine into ben-
zoylecgonine is increased (16). The solution of formalin used by
us was at neutral pH, and this value (pH 7.0) may not have pre-
vented the transformation of cocaine into benzoylecgonine.
So, because many processes may cause cocaine breakdown,
cocaine itself may not be found in liver at the time of autopsy,
even with timely screening and confirmation (7). Other au-
thors have frequently had cases in which a toxicology screen de-
tects only moderate concentrations of benzoylecgonine and
no cocaine (17).
The only case in which we detected cocaine in fresh tissue
was a cocaine-related death. In the other three cases, cocaine
was incidental to the cause of death. Other authors have also
found cocaine in postmortem liver, especially in cases of over-
dose, but not frequently when cocaine was incidental to the
cause of death (7).
Our results highlight the fact that the quantitative values of
cocaine and benzoylecgonine obtained in fixed tissues and from
the same tissues at the time of autopsy are quite different. The
level of benzoylecgonine, increased in the formalin water
solutions, demonstrated leaching of the drug from the liver into
the formalin solutions. In all cases, the concentrations in for-
malin solutions in which liver was preserved were found to be
higher than those recovered in the same fixed tissues and in
fresh tissues. This remarkable fact is probably because of the ex-
traction capability of formalin solution.
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Table I. Quantitation of Cocaine and Benzoylecgonine in
Liver Tissue at Time of Autopsy in Fixed Tissues and
Formalin Solutions
Liver at Time 
of Autopsy Fixed Liver Formalin 
Case (mg/kg) (mg/kg) Liver (mg/L)
1 COC: 0.376 BZE: 0.056 BZE: 0.885
BZE: 0.423
2 BZE: 0.816 BZE: 0.104 BZE: 0.509
3 BZE: 0.162 BZE: 0.024 BZE: 0.124
4 BZE: 0.815 BZE: 0.135 BZE: 0.672
* Abbreviations: COC = cocaine and BZE = benzoylecgonine.
Table II. Means of Quantitative Results for
Benzoylecgonine (Amounts) and Rate of Recovery after
Four Weeks
Amount Amount 
Amount of of BZE in of BZE in % of % of 
BZE at Time Fixed Formalin Recovery Recovery
of Autopsy Tissues Solutions Fixed in in Formalin 
(means, µg) (means, µg) (means, µg) Tissues Solutions
3.24† 0.399 2.737 12.31 84.47
* Abbreviations: COC = cocaine and BZE = benzoylecgonine.
† COC and BZE are considered as BZE.
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Formaldehyde is a highly reactive chemical substance and has
recently been shown to react with some drugs (18,19). As re-
gards cocaine and benzoylecgonine, this type of interaction
can be excluded. In fact, as shown in Table II, the total sums of
drugs in formalin solution and fixed tissues are comparable
with those in fresh tissues. The absence of any differences in-
dicates that benzoylecgonine has good stability and does not
react chemically with formaldehyde.
Conclusions
The good stability of benzoylecgonine in biological speci-
mens submitted to chemical fixation allows fixed tissues to be
used for forensic toxicology diagnosis of cocaine poisoning in
cases in which toxicology analysis for the substance was not car-
ried out at the time of autopsy. However, interpretation of quan-
titative data from fixed tissues requires considerable care. The
formalin solutions in which the tissues were preserved can also
be used for the same purpose. The double evaluation of ben-
zoylecgonine in fixed tissues and formalin solutions provides a
good indication of the original quantity of cocaine in the same
tissues before fixation.
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